Monday, August 24, 2026

BTC $79,110 ▲ 1.77%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.222−2.08%ETH$2,479+0.65%LINK$11.54+0.02%SOL$96.11+0.72%BTC$79,110+1.77%XRP$1.50−1.32%S&P 5007,660−0.19%Nasdaq26,068−0.43%Dow53,390+0.21%RUT2,998−0.65%TNX4.69%−0.97%TYX5.22%−1.14%FVX4.40%−0.47%IRX3.71%−0.08%VIX15.68+3.64%GOLD$4,712.80+0.69%SILVER$68.80−1.06%OIL$85.32−2.00%DXY98.99+0.19%NVDA$209.67−2.35%AAPL$313.04+1.19%TSLA$354.99−2.17%META$557.71+1.42%MSFT$488.92+1.18%AMZN$262.96+1.67%GOOGL$350.90+1.76%Fear & Greed73 — GreedADA$0.222−2.08%ETH$2,479+0.65%LINK$11.54+0.02%SOL$96.11+0.72%BTC$79,110+1.77%XRP$1.50−1.32%S&P 5007,660−0.19%Nasdaq26,068−0.43%Dow53,390+0.21%RUT2,998−0.65%TNX4.69%−0.97%TYX5.22%−1.14%FVX4.40%−0.47%IRX3.71%−0.08%VIX15.68+3.64%GOLD$4,712.80+0.69%SILVER$68.80−1.06%OIL$85.32−2.00%DXY98.99+0.19%NVDA$209.67−2.35%AAPL$313.04+1.19%TSLA$354.99−2.17%META$557.71+1.42%MSFT$488.92+1.18%AMZN$262.96+1.67%GOOGL$350.90+1.76%Fear & Greed73 — Greed

Tag

Cancer Vaccine

2 articles

U.S. Equities2d ago

Moderna Stock Drops 25% on Cancer Vaccine Success—Wall Street's Skepticism Shows Risk

Investors sold despite positive melanoma vaccine trial results, pointing to lingering doubts about Moderna's ability to execute beyond COVID and generate sustainable returns.

Research & Analysis5d ago

Merck, Moderna's mRNA Melanoma Vaccine Succeeds in Phase 3 Trial

Intismeran, combined with Keytruda, reduced melanoma recurrence—the first neoantigen vaccine to clear a late-stage randomized trial.